BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

688 related articles for article (PubMed ID: 8830833)

  • 1. Costimulatory molecule-deficient dendritic cell progenitors (MHC class II+, CD80dim, CD86-) prolong cardiac allograft survival in nonimmunosuppressed recipients.
    Fu F; Li Y; Qian S; Lu L; Chambers F; Starzl TE; Fung JJ; Thomson AW
    Transplantation; 1996 Sep; 62(5):659-65. PubMed ID: 8830833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blockade of the CD40-CD40 ligand pathway potentiates the capacity of donor-derived dendritic cell progenitors to induce long-term cardiac allograft survival.
    Lu L; Li W; Fu F; Chambers FG; Qian S; Fung JJ; Thomson AW
    Transplantation; 1997 Dec; 64(12):1808-15. PubMed ID: 9422424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased apoptosis of immunoreactive host cells and augmented donor leukocyte chimerism, not sustained inhibition of B7 molecule expression are associated with prolonged cardiac allograft survival in mice preconditioned with immature donor dendritic cells plus anti-CD40L mAb.
    Lu L; Li W; Zhong C; Qian S; Fung JJ; Thomson AW; Starzl TE
    Transplantation; 1999 Sep; 68(6):747-57. PubMed ID: 10515374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone marrow-derived dendritic cell progenitors (NLDC 145+, MHC class II+, B7-1dim, B7-2-) induce alloantigen-specific hyporesponsiveness in murine T lymphocytes.
    Lu L; McCaslin D; Starzl TE; Thomson AW
    Transplantation; 1995 Dec; 60(12):1539-45. PubMed ID: 8545887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microchimerism, dendritic cell progenitors and transplantation tolerance.
    Thomson AW; Lu L; Murase N; Demetris AJ; Rao AS; Starzl TE
    Stem Cells; 1995 Nov; 13(6):622-39. PubMed ID: 8590864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasmacytoid dendritic cell precursors induce allogeneic T-cell hyporesponsiveness and prolong heart graft survival.
    Abe M; Wang Z; de Creus A; Thomson AW
    Am J Transplant; 2005 Aug; 5(8):1808-19. PubMed ID: 15996227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microchimerism, donor dendritic cells, and alloimmune reactivity in recipients of Flt3 ligand-mobilized hemopoietic cells: modulation by tacrolimus.
    Morelli AE; Antonysamy MA; Takayama T; Hackstein H; Chen Z; Qian S; Zurowski NB; Thomson AW
    J Immunol; 2000 Jul; 165(1):226-37. PubMed ID: 10861056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T-cell alterations in cardiac allograft recipients after B7 (CD80 and CD86) blockade.
    Woodward JE; Bayer AL; Chavin KD; Blue ML; Baliga P
    Transplantation; 1998 Jul; 66(1):14-20. PubMed ID: 9679816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Donor bone marrow potentiates the effect of tacrolimus on nonvascularized heart allograft survival: association with microchimerism and growth of donor dendritic cell progenitors from recipient bone marrow.
    Khanna A; Steptoe RJ; Antonysamy MA; Li W; Thomson AW
    Transplantation; 1998 Feb; 65(4):479-85. PubMed ID: 9500620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Flt-3 ligand on donor-derived antigen presenting cells and alloimmune reactivity in heart graft recipients given adjuvant donor bone marrow.
    Khanna A; Antonysamy MA; Subbotin VM; Steptoe RJ; Li W; Rudert WA; Thomson AW
    Transpl Immunol; 1998 Dec; 6(4):225-34. PubMed ID: 10342736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro propagation and homing of liver-derived dendritic cell progenitors to lymphoid tissues of allogeneic recipients. Implications for the establishment and maintenance of donor cell chimerism following liver transplantation.
    Thomson AW; Lu L; Subbotin VM; Li Y; Qian S; Rao AS; Fung JJ; Starzl TE
    Transplantation; 1995 Feb; 59(4):544-51. PubMed ID: 7878760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retroviral delivery of transforming growth factor-beta1 to myeloid dendritic cells: inhibition of T-cell priming ability and influence on allograft survival.
    Takayama T; Kaneko K; Morelli AE; Li W; Tahara H; Thomson AW
    Transplantation; 2002 Jul; 74(1):112-9. PubMed ID: 12134108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone marrow-derived immature dendritic cells prime in vivo alloreactive T cells for interleukin-4-dependent rejection of major histocompatibility complex class II antigen-disparate cardiac allograft.
    Buonocore S; Flamand V; Goldman M; Braun MY
    Transplantation; 2003 Feb; 75(3):407-13. PubMed ID: 12589166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "Alternatively activated" dendritic cells preferentially secrete IL-10, expand Foxp3+CD4+ T cells, and induce long-term organ allograft survival in combination with CTLA4-Ig.
    Lan YY; Wang Z; Raimondi G; Wu W; Colvin BL; de Creus A; Thomson AW
    J Immunol; 2006 Nov; 177(9):5868-77. PubMed ID: 17056511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trafficking of APC from liver allografts of Flt3L-treated donors: augmentation of potent allostimulatory cells in recipient lymphoid tissue is associated with a switch from tolerance to rejection.
    Steptoe RJ; Li W; Fu F; O'Connell PJ; Thomson AW
    Transpl Immunol; 1999 Mar; 7(1):51-7. PubMed ID: 10375078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Propagation of dendritic cell progenitors from normal mouse liver using granulocyte/macrophage colony-stimulating factor and their maturational development in the presence of type-1 collagen.
    Lu L; Woo J; Rao AS; Li Y; Watkins SC; Qian S; Starzl TE; Demetris AJ; Thomson AW
    J Exp Med; 1994 Jun; 179(6):1823-34. PubMed ID: 8195710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heart, but not skin, allografts from donors lacking Flt3 ligand exhibit markedly prolonged survival time.
    Wang Z; Castellaneta A; De Creus A; Shufesky WJ; Morelli AE; Thomson AW
    J Immunol; 2004 May; 172(10):5924-30. PubMed ID: 15128773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preferential induction of Th1 responses by functionally mature hepatic (CD8alpha- and CD8alpha+) dendritic cells: association with conversion from liver transplant tolerance to acute rejection.
    Morelli AE; O'Connell PJ; Khanna A; Logar AJ; Lu L; Thomson AW
    Transplantation; 2000 Jun; 69(12):2647-57. PubMed ID: 10910289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis.
    Shimizu K; Schönbeck U; Mach F; Libby P; Mitchell RN
    J Immunol; 2000 Sep; 165(6):3506-18. PubMed ID: 10975872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for a role of IL-17 in organ allograft rejection: IL-17 promotes the functional differentiation of dendritic cell progenitors.
    Antonysamy MA; Fanslow WC; Fu F; Li W; Qian S; Troutt AB; Thomson AW
    J Immunol; 1999 Jan; 162(1):577-84. PubMed ID: 9886435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.